Hara Y, Miyamoto Y, Hiyoshi Y, Iwatsuki M, Baba Y, Yoshida N, Baba H. Severe Encephalopathy, Lactic Acidosis and Hyperammonaemia With FOLFIRI Plus Aflibercept After Two-stage Hepatectomy: A Case Report.
In Vivo 2019;
33:563-565. [PMID:
30804142 DOI:
10.21873/invivo.11511]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2018] [Revised: 12/24/2018] [Accepted: 12/26/2018] [Indexed: 12/22/2022]
Abstract
BACKGROUND/AIM
Recent advances in chemotherapy have increased the possibility of conversion hepatectomy for patients with initially unresectable liver metastases. Although long-term chemotherapy and subsequent extensive hepatectomy are becoming more common, the toxicities of such chemotherapies are unclear.
PATIENTS AND METHODS
We present a case report of a patient with metastatic colorectal cancer who developed severe encephalopathy with lactic acidosis and hyperammonaemia caused by 5-fluorouracil-based chemotherapy. Administration of vitamin B1 and continuous haemodiafiltration rapidly improved the patient's symptoms.
CONCLUSION
Intensive treatment of metastatic colorectal cancer patients with 5-fluorouracil can induce rare adverse events.
Collapse